Not Yet Recruiting
To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer
NCT07370818
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine Seoul, South Korea